Ann: Acrux confirms patent challenge for generic of efinaconazole, page-11

  1. 468 Posts.
    lightbulb Created with Sketch. 59
    Acrux would have only known about the challengers at the same time the public did; when the cases were brought to court. So they knew there were 7 challengers by early last week. Then the extra 6 last Friday morning (AEST).

    From a broad investor perspective, comfort can be taken in the price fall directly after the announcement today. Given there was no new information therein, it's always reassuring to see market inefficiencies.
    Last edited by long_haul: 24/09/18
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.8¢
Change
0.000(0.00%)
Mkt cap ! $7.366M
Open High Low Value Volume
1.8¢ 1.8¢ 1.8¢ $1.8K 100K

Buyers (Bids)

No. Vol. Price($)
1 135000 1.8¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 427217 5
View Market Depth
Last trade - 13.13pm 28/07/2025 (20 minute delay) ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.